Mike Nash

Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically optimized host, data-driven process development, and a novel, right-sized manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that they plan to deploy worldwide.